Cozaar and Tobramycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cozaar (losartan potassium) and Tobramycin (tobramycin). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Cozaar and Tobramycin. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Cozaar?

Cozaar has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 45,124 Cozaar users. Check the latest studies of Cozaar.

What is Tobramycin?

Tobramycin has active ingredients of tobramycin. It is often used in cystic fibrosis. eHealthMe is studying from 3,579 Tobramycin users. Check the latest studies of Tobramycin.

On Jul, 14, 2026

15 people who take Cozaar and Tobramycin together, and have interactions are studied.

Cozaar and Tobramycin drug interactions.

What are the common drug interactions of Cozaar and Tobramycin, by gender? *:

female:

Chronic kidney disease
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Nephrogenic anaemia (anaemia due to kidney disease)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal failure (kidney dysfunction)

male:

Chronic kidney disease
Pain
Hypotension (abnormally low blood pressure)
Mass
Nephrogenic anaemia (anaemia due to kidney disease)
Prostate cancer
Emotional distress
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Decreased appetite
Discomfort

What are the common drug interactions of Cozaar and Tobramycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Renal injury (kidney injury)
Renal tubular necrosis (death of kidney tubules)
Weight decreased

40-49:

Respiratory syncytial virus infection (viral disease of respiratory system)

50-59:

Hypercholesterolaemia (high levels of cholesterol in the blood)
Multiple fractures
Osteonecrosis (death of bone)
Osteopenia (a condition where bone mineral density is lower than normal)
Pain
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Renal injury (kidney injury)
Tooth loss
Chronic kidney disease

60+:

Chronic kidney disease
Depression
Renal failure (kidney dysfunction)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Decreased appetite
Discomfort
Fatigue (feeling of tiredness)
Infection
Muscle spasms (muscle contraction)
Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 66.67%
High Blood Cholesterol: 5 people, 33.33%
Infection: 5 people, 33.33%
Diabetes: 5 people, 33.33%
Blood Pressure Abnormal: 4 people, 26.67%
Pain: 4 people, 26.67%
Dyspnea (difficult or laboured breathing): 3 people, 20.00%
Hypersensitivity: 3 people, 20.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 3 people, 20.00%
Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cozaar and Tobramycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously